Minireviews
Copyright ©The Author(s) 2018.
World J Hepatol. Oct 27, 2018; 10(10): 702-707
Published online Oct 27, 2018. doi: 10.4254/wjh.v10.i10.702
Table 1 Comparison of benefits and disadvantages among 3 types of cell sources, mesenchymal stem cells, induced pluripotent stem and embryogenic stem cells
MSCiPS cellsES cells
ProliferationLowHighHigh
DifferentiationLimitedPluripotentPluripotent
Gene transferNoYesNo
Cancer riskLowNot neglectedNot neglected
Immune rejectionLowPossibleHigh
Paracrine mechanismYesUnknownUnknown
BankingEasyEasyPossible
Ethical hurdleLowLowHigh